At Bio Med Sciences, we continue to develop innovative solutions. Our patented lines of wound care, scar management, and renewing technology products are industry leading.
Concerned about unsightly scars or wrinkles? We have the solution.
We have the products you need to maximize your patients’ outcomes.
Our skilled team specialize in skin adhesive systems and thin film production.
Available exclusively from Bio Med and through authorized business partners.
Concerned about unsightly scars or wrinkles? We have the solution.
We have the products you need to maximize your patients’ outcomes.
Whether you treat acute burn injuries, manage the long and intensive rehabilitation process, or perform cosmetic surgery procedures, our products help you maximize outcomes.
Our skilled team specialize in skin adhesive systems and thin film production.
We offer custom design, development & manufacturing services in a wide range of technological areas. Our R&D professionals specialize in novel skin adhesive systems and thin film production.
Available exclusively from Bio Med and through authorized business partners.
Silon® products are available exclusively from Bio Med and authorized distributors. If you are interested in becoming a valued partner, please contact us to explore opportunities in your market.
Since 1987, Bio Med Sciences has been improving lives with creative solutions for healthcare providers and consumers around the world. Our Silon® technology blends the best properties of silicone and Teflon®, enabling us to develop new and innovative products for wound care, scar management, and skin renewing technologies.
Our Silon-TSR®, Dual-Dress 50®, and Rylon-1® lines of wound care products provide professional healthcare providers with advanced solutions for burn treatment, dermatology, cosmetic surgery, long-term care and rehabilitation applications.
Our Silon® and Oleeva® brands of scar management products are uniquely designed for professional and consumer use. We offer the only family of scar management products in the market, each item designed to meet a specific clinical need.
Silon-TSR® demonstrated more comfort and better durability as compared to a conventional biosynthetic dressings for skin sloughing syndrome management.
Use of Silon-LTS® provided a cost-effective scar device that has reduced the contracture and hastened the need for contracture release.
Cost effective treatment – the durability of Silon-STS® allows the silicone layer to last the life of the splint, far exceeding the use of other materials for this scar application.
Bio Med Sciences is improving the lives of patients and consumers around the world through the development of innovative biomedical solutions.
Lehigh Valley Suite Spot is a monthly interview series featuring Lehigh Valley executives from a wide range of industries and company sizes.
Mark Dillon, CEO for Bio Med Sciences, was interview for the December series. For the full interview, click on the following link:
https://lehighvalley.org/bio-med-sciences-mark-dillon/
We’re Taking Flight at our New Manufacturing Site!
June 1, 2021 – 999 Postal Road, Allentown, PA
Bio Med Sciences has relocated its Fogelsville manufacturing facility to a new site adjacent to Lehigh Valley International Airport. At 999 Postal Road, the Company’s has tripled its space to accommodate growth and new opportunities. Over the coming months the Company will transition into the new facility, first with administrative and warehouse functions to be followed by full manufacturing and laboratory operations. In addition to more room to grow, the Company is investing heavily in new manufacturing equipment, more than doubling its production capacity and adding new capabilities! Approaching its 35th anniversary, the team at Bio Med is thrilled to share this exciting news with our friends and customers!
Our phone numbers, email addresses and web site all remain the same.
We are excited to continue our Mission:
Improving the lives of patients and consumers around the world through the development of innovative biomedical solutions.
We look forward to working with you from our new location!
Bio Med Sciences, Inc. wants to take this opportunity to tell you of our efforts with respect to the novel coronavirus, COVID-19.
Our workers’ safety and well-being is our highest priority, as is the safety and well-being of our customers and the general public. We have advised our employees about how to take care of themselves, protect others, and monitor the latest developments. Per the U.S.
Centers for Disease Control and Prevention, we have informed our employees that they
should:
• Avoid close contact with people who are sick
• Avoid touching their eyes, nose, and mouth
• Stay home when they are sick
• Cover their cough or sneeze with a tissue, then throw the tissue in the trash
• Clean and disinfect frequently touched objects and surfaces using a regular household cleaning spray or wipe
• Follow CDC’s recommendations for using a face mask
• Wash their hands often
We also have encouraged our employees to keep up-to-date on developments by visiting the About Coronavirus Disease 2019 and CDC’s Frequently Asked Questions and Answers webpages. In addition, we are asking employees to follow guidelines in CDC’s Travel
Information -Travelers Returning from High Risk Countries.
Bio Med Sciences, Inc. is open for business and will continue to serve our customers to the best of our ability during this time. We have taken steps to maintain business operations and minimize any adverse effects on other entities in our supply chain. Serving your needs in a safe manner is of the utmost importance to us. As a medical device manufacturer, we recognize our responsibility to the global community and appreciate your continued trust in us. Please feel free to contact us at +l (610) 530-3193 or (800) 257-4566
Mark E. Dillon
President & CEO
Bio Med Sciences (“Bio Med”) is pleased to announce it has recently entered into a Cooperative Research and Development Agreement (“CRADA”) with the United States Army Institute of Surgical Research (“USAISR”).
The purpose of the CRADA is to jointly develop a new antimicrobial wound dressing for battlefield deployment. USAISR is contributing its skill and technology in chemical formulation and antimicrobial testing, while Bio Med will contribute its knowhow and proprietary manufacturing methods to develop the product on a commercial scale. It is anticipated that several iterations of the technology and manufacturing methods will be evaluated over the 3-year span of the CRADA, with the ultimate goal of producing a commercially available, FDA cleared wound dressing.
Mark Dillon, President & CEO of Bio Med said: “This is a great opportunity to bring together two organizations with complimentary technologies and capabilities that will not only benefit America’s armed forces but the general public as well.”
Dr. Kai P. Leung, Capability Area Manager for Severe Burns and Senior Scientist in Department of Dental and Craniofacial Trauma of USAISR is the director of the CRADA program with Bio Med at USAISR.
Since 1987, Bio Med has delivered leading technology to the burn treatment, plastic surgery and aesthetic skin care markets. Their proven, patented Silon® technology provides a versatile platform for a wide range of medical products. With over 60 patents to its credit, Bio Med has successfully developed its technology into the Silon®, Oleeva® and SeaAllure™ lines of products. The company sells directly to patients, consumers and clinical practices as well as through distributors. Silon® products are available exclusively from Bio Med and through authorized business partners. Oleeva® and SeaAllure™ products can be purchased directly from the company’s web site.
Dave with healtheo360 talks with President and CEO of Bio Med Sciences, Mark Dillon, about his development of Silon material and founding the company at the age of 24. Bio Med Sciences creates products that assist with wound care, scar management and skin renewal. Dave discusses with Mark about the burn healing process, and how Bio Med Sciences creates innovative solutions for patients and physicians.
Part 1
Part 2
Part 3
Silon-TSR® demonstrated more comfort and better durability as compared to a conventional biosynthetic dressings for skin sloughing syndrome management. Additionally, there were significant differences resulting in less nursing time required per dressing; decreased overall pain assessment and decreased costs using the Silon® material.
Awesome Customer Service! I ordered yesterday; order received today! Can’t wait to use it! Thank You!
The meshed autograft site provided an excellent basis for comparison – the Silon-TSR® allowed the interstices of the graft to close more rapidly…allowed increased moisture vapor transmission…additionally, the fresh epithelium was not disrupted when the dressing was removed.
The Dual-Dress 50® dressing maintains a high absorbency (8.2 grams water per gram of foam) while demonstrating minimal changes in swelling or expansion (<20%) – further providing consistent graft contact. We now use this dressing on essentially all cases where mechanical protection and shielding of the wound is required and have found this to be significantly useful for difficult burn management.
Oleeva® Fabric had the ideal combination of elasticity and strength to overcome mild eyelid retraction and prevent further contracture. Furthermore, the silicone lining safely adhered to the skin, softening the scar and providing gentle compression – both key tenants of effective scar management.
Cost effective treatment – the durability of Silon-STS® allows the silicone layer to last the life of the splint, far exceeding the use of other individual silicone gel sheets and splint materials for this scar application. This material provides another useful and effective treatment option for the burn therapist to employ in the management of neck and chin scar hypertrophy.
In the Spring of this year I had surgery, used your scar shape product for 12wks, very happy with the results. You have a great product and excellent customer service, all at a reasonable price. You DO have a superior product. In my work I am frequently asked for referrals, including scar management post-plastic surgery, and I am happy to recommend your scar shapes.
Use of Silon-LTS® provided a cost effective scar device that has reduced the contracture and hastened the need for contracture release. Additionally, the combined use of pressure and silicone in this material helps to enhance compliance in the pediatric population and facilitate cosmeis with only limited use.
The Silon-TSR® dressing application decreases immediate postoperative morbidity and significantly reduces the severity and duration of erythema, and decreases the duration of swelling and crusting after laser resurfacing procedures.
Advantages of the Silon-TSR® include nonadherence to the wound, no tendency to reinjure the wound with removal, the accumulation of growth factors at the wound surface and oxygen exchange. Patients prefer the dressing due to increased mobility, less accumulation of exudates at the base of the dressing and no adherence to the wound…patients rated cosmetic results better at 6 months as compared to our SOC dressings.
